Cardiology World Conference, October 24-25, 2019 | Tokyo, Japan
One of the themes of this conference is that of myocardial ischaemia and infarction. At first glance, this would seem to represent purely a repetition of our previous focus on the traditional theme of a common spectrum of cardiovascular disorders driven by the traditional risk factors of hypertension, smoking, diabetes and poor diet, and emerging mainly in middle-aged men. Our therapeutic discussion 30 years ago would have emphasised coronary revascularization above all. However, much has changed. In Western societies, emergence of coronary atheroma-related disease has generally been delayed, if not prevented, while an emerging epidemic threatens the Third World. We have finally learned the importance of inflammation as a key component of the pathogenesis of atherogenesis and myocardial Welcome Message ischaemia, and are beginning to refine our pharmacotherapy to accommodate the recognition of its potential effectiveness and the emergence of “new” forms of acute heart disease which occur mainly in women. I welcome you to the ischaemia/infarction section of the Conference, and trust that you will find our discussions exciting and providing of a better guide to future treatment.
